Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open‐label, randomized controlled trial
Sign Up to like & getrecommendations! Published in 2021 at "Cancer"
DOI: 10.1002/cncr.34074
Abstract: This multicenter clinical trial was designed to evaluate the efficacy and safety of thalidomide (THD) in preventing oral mucositis (OM) in patients with nasopharyngeal carcinoma (NPC) undergoing concurrent chemoradiotherapy (CCRT). read more here.
Keywords: safety thalidomide; preventing oral; patients nasopharyngeal; efficacy safety ... See more keywords
An Integrated Approach for Preventing Oral Cavity and Oropharyngeal Cancers: Two Etiologies with Distinct and Shared Mechanisms of Carcinogenesis
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Prevention Research"
DOI: 10.1158/1940-6207.capr-20-0096
Abstract: Head and neck squamous cell carcinoma (HNSCC) was the 7th most common malignancy worldwide in 2018 and despite therapeutic advances, the overall survival rate for oral squamous cell carcinoma (OSCC; ∼50%) has remained unchanged for… read more here.
Keywords: integrated approach; cell carcinoma; squamous cell; preventing oral ... See more keywords